Skip to main content
. 2022 Apr 2;45(Suppl 2):S85–S90. doi: 10.1016/j.htct.2022.02.005

Table 2.

Asymptomatic patients.

Patient Age (years) Setting Underlying disease Risk factors Reason for imaging Anticoagulation therapy Treatment duration Radiological follow-up (6 months)
#1 14 Inpatient (20 days) Metastatic osteosarcoma Malignancy Tumor staging Enoxaparin, 1 mg/kg/dose q12h 10 months Chronic PE
#2 2 Inpatient (22 days) T-cell acute lymphoblastic leukemia Malignancy + Drug¹ + Infection + CVC² Fever of unknown origin Enoxaparin, 1 mg/kg/dose q12h 6 months Chronic PE
#3 15 Outpatient Metastatic Ewing sarcoma Malignancy Tumor staging Enoxaparin, 1.2 mg/kg/dose q12h 3 months Complete resolution
#4 2 Inpatient (33 days) Double outlet right ventricle + Interatrial and interventricular communication Congenital heart disease + Recent surgery + CVC Postoperative imaging control Enoxaparin, 1.4 mg/kg/dose q12h Not reported Complete resolution
#5 3 Inpatient (8 days) Right adrenocortical carcinoma Malignancy + Recent surgery Postoperative imaging control Enoxaparin, 1 mg/kg/dose q12h 3 months Complete resolution
¹

Asparaginase;

²

Central venous catheter.